HPGC Renmintongtai Pharmaceutical PEG Ratio

HPGC Renmintongtai Pharmaceutical (600829.SS) currently reports a PEG ratio of 178.94. That is above the sector sector average of 10.05. Use the charts on this page to explore HPGC Renmintongtai Pharmaceutical's PEG ratio history and peer comparisons.

HPGC Renmintongtai Pharmaceutical's PEG ratio of 178.94 is higher than the its sector sector average of 10.05. That is roughly 1679.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates HPGC Renmintongtai Pharmaceutical's market price to a fundamental measure such as earnings, sales, or book value. At 178.94, 600829.SS can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 178.94, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.05. From there, open related valuation or income-statement pages for HPGC Renmintongtai Pharmaceutical, and consider following 600829.SS for alerts when major investors trade the stock.